The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Personalized Ophthalmology Therapies Market Evolve From 2026 To 2030?
The personalized ophthalmology therapies market has experienced significant expansion in recent years. It is projected to increase from $3.23 billion in 2025 to $3.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.2%. The historical development of this market is linked to factors such as advancements in retinal disease research, the growing prevalence of chronic eye disorders, the establishment of more ophthalmology specialty clinics, improvements in ocular imaging technologies, and an increase in clinical trial activity for eye diseases.
The personalized ophthalmology therapies market is poised for substantial expansion over the next few years, with its valuation expected to climb to $6.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.0%. This anticipated growth during the forecast period is fueled by an uptick in approvals for gene and cell therapies, increased investments in precision ophthalmology research, the broadening scope of personalized treatment protocols, growing adoption of sophisticated drug delivery platforms, and a rising demand for solutions aimed at long-term vision preservation. Prominent trends throughout this period include the intensifying development of gene-based ophthalmic therapies, the increasing embrace of biomarker-guided treatment approaches, wider application of advanced retinal imaging for therapy selection, the expansion of targeted drug delivery systems, and an enhanced focus on tailored disease management.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28295&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Personalized Ophthalmology Therapies Market?
The increasing occurrence of chronic vision disorders is anticipated to propel the expansion of the personalized ophthalmology therapies market moving forward. These disorders are defined as persistent eye conditions that progressively impair sight and frequently necessitate continuous management over an extended period. The global rise in diabetes prevalence contributes to the increase in chronic vision disorders, as diabetes can lead to complications such as diabetic retinopathy, which gradually damages the eyes over time. Personalized ophthalmology therapies benefit chronic vision disorders by developing customized treatment plans based on an individual’s unique genetic and molecular profile, which enhances treatment effectiveness and aids in slowing the disease’s progression. As an illustration, the Centers for Disease Control and Prevention (CDC), a US-based government agency, indicated in May 2024 that without effective measures, cases of diabetic retinopathy are projected to rise by 72%, while cataract cases are expected to grow by 87% by 2050. Consequently, the expanding prevalence of chronic vision disorders is a key factor driving the growth of the personalized ophthalmology therapies market.
Which Segment Areas Are Covered In The Personalized Ophthalmology Therapies Market Analysis?
The personalized ophthalmology therapies market covered in this report is segmented –
1) By Therapy Type: Gene Therapy, Cell Therapy, Pharmacogenomics, Targeted Drug Delivery, Other Therapy Types
2) By Indication: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinitis Pigmentosa, Other Indications
3) By End User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users
Subsegments:
1) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, CRISPR Or Cas9-Based Gene Editing
2) By Cell Therapy: Stem Cell Therapy, Retinal Pigment Epithelial (RPE) Cell Therapy, Induced Pluripotent Stem Cell (iPSC) Therapy
3) By Pharmacogenomics: Drug Response Testing, Genetic Biomarker-Based Therapy, Personalized Drug Dosing
4) By Targeted Drug Delivery: Nanoparticle-Based Delivery, Liposomal Drug Delivery, Hydrogel-Based Delivery Systems
5) By Other Therapy Types: RNA-Based Therapy, Antisense Oligonucleotide Therapy, Peptide-Based Therapy
Which Trends Are Shaping The Future Of The Personalized Ophthalmology Therapies Market?
Key companies operating in the personalized ophthalmology therapies market are concentrating on developing advanced solutions, such as one-time intravitreal gene therapies, to reduce patient burden and mitigate the risk of complications associated with multiple injections. These one-time intravitreal gene therapies involve a single injection into the eye’s vitreous cavity to deliver genetic material that addresses or modifies underlying eye disorders, offering lasting therapeutic effects. For instance, in July 2025, Sanofi, a pharmaceutical and healthcare company based in France, announced that the US Food and Drug Administration (FDA) had approved fast track designation for SAR446597. This is a single-dose intravitreal gene therapy designed to treat geographic atrophy (GA) caused by age-related macular degeneration (AMD). It received fast-track designation to accelerate its development and regulatory review for serious conditions with unmet medical needs. The therapy introduces genetic material encoding two antibody fragments that block C1s in the classical complement pathway and factor Bb in the alternative pathway. This dual-action mechanism aims to provide long-lasting complement suppression in the retina, targeting the disease process while minimizing the necessity for repeated injections.
Which Global Companies Are Actively Competing In The Personalized Ophthalmology Therapies Market?
Major companies operating in the personalized ophthalmology therapies market are Roche Holding AG, Novartis AG, Regeneron Pharmaceuticals Inc., Alcon Inc., Genentech Inc., Bausch + Lomb Corporation, Johnson & Johnson Vision Care Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Senju Pharmaceutical Co. Ltd., MeiraGTx Ltd., Beacon Therapeutics, Clearside Biomedical Inc., Adverum Biotechnologies Inc., Ocugen Inc., GenSight Biologics, Nanoscope Therapeutics Inc., 4D Molecular Therapeutics Inc., Coave Therapeutics.
Read the full personalized ophthalmology therapies market report here:
What Are The Leading Geographic Regions In The Personalized Ophthalmology Therapies Market?
North America was the largest region in the personalized ophthalmology therapies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized ophthalmology therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Personalized Ophthalmology Therapies Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28295&type=smp
Browse Through More Reports Similar to the Global Personalized Ophthalmology Therapies Market 2026, By The Business Research Company
Personalized Medicine Global Market Report
https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report
Bioinformatics Services Global Market Report
https://www.thebusinessresearchcompany.com/report/bioinformatics-services-global-market-report
Genomics Personalized Health Global Market Report
https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
